Frost & Sullivan Lauds FCMB ApS for Its Breakthrough Work in Non-invasive Prenatal Testing

LONDON, June 30, 2010 – Frost & Sullivan is pleased to announce that it has awarded its
prestigious 2010 Scandinavia New Product Innovation Award to FCMB ApS
("FCMB") for its breakthrough work in non-invasive prenatal testing. FCMB is
developing a suite of non-invasive prenatal diagnostics based on isolating
fetal cells from maternal blood samples. FCMB's diagnostics have the
potential [...]

Centris AG – Strong Customer Support Thanks to CA Technologies

The Leading Swiss IT Service Provider for Health and Accident Insurers Relies on CA Service Desk Manager to Pursue a No-compromise Policy When it Comes to Top Quality Customer Support

ZURICH, June 30, 2010 – The leading Swiss IT service provider for health and accident insurers,
Centris AG, based in Solothurnsupports around 4,500 users in [...]

Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation

CLEVELAND, Ohio, June 30, 2010 – Simbionix Ltd., a subsidiary of Simbionix USA Corporation, the world's
leading provider of medical education and simulation training products for
medical professionals and the healthcare industry, and USF Health, an
organization dedicated to creating a model of health care based on
understanding the full spectrum of health, are proud to announce that
together [...]

Over 40,000 Food Professionals at FiA | Hi | Ni China 2010

SHANGHAI, June 30, 2010 – FiA | Hi | Ni China 2010, alongside Food Ingredients Shanghai (FIS 2010)
and CPhI China 2010, kicked off at Shanghai New International Expo Center on
June 2nd-4th, 2010. Professionals from the global food's raw materials and
ingredients market gathered under one roof in the main event of the industry.

[...]

Shire Purchases Strategic Site in Massachusetts

Transaction Allows Company to Continue its Growth
LEXINGTON, Massachusetts, June 30, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced its purchase of the Lexington
Technology Park campus in Lexington, Massachusetts. The purchase signifies an
investment in the growth of its Human Genetic Therapies (HGT) business, which
focuses on the discovery, development, and [...]

Taking Fundraising to New Heights – MediciGlobal’s Global eMarketing Director Jumps from 10,000 feet for Alzheimer’s Research

MediciGlobal team members lead the way in 'Extreme Charity'
KING OF PRUSSIA, Pennsylvania, and LONDON, June 30, 2010 – Participating in 'extreme charity' events aptly describes the commitment
of MediciGlobal's employees to raising money for noteworthy causes. Last
year, one of MediciGlobal's new project leaders climbed Kilimanjaro for
cancer research, and this year, the same executive is embarking [...]

Celsis Seeks Injunction Against Invitrogen for LiverPool(TM) Patent Infringement

BALTIMORE, June 30, 2010 – Celsis In Vitro, Inc. (Celsis IVT) announced today that it has filed a
patent infringement lawsuit against Invitrogen Corporation (Invitrogen) and
CellzDirect, Inc. (CellzDirect) in the United States District Court for the
Northern District of Illinois in Chicago and has moved for a preliminary
injunction. Invitrogen, the parent of CellzDirect, is itself a [...]

Gen-Probe Receives European CE Mark for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis

SAN DIEGO, June 30, 2010 – Gen-Probe Incorporated (Nasdaq: GPRO) announced today that it has
received a European CE mark for its APTIMA(R) assay for Trichomonas
vaginalis, a common parasitic sexually transmitted disease.

Gen-Probe's APTIMA Trichomonas assay utilizes the same nucleic acid
amplification technologies as the APTIMA COMBO 2(R) assay, the Company's
market-leading test for [...]

Eiger BioPharmaceuticals Announces New HCV Synergy Data

Publication describes high level of synergy of clemizole with protease inhibitor class

PALO ALTO, California, July 1, 2010 – Eiger BioPharmaceuticals, Inc., a biotechnology company developing
antiviral therapies, announced today the publication of research from the lab
of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and
colleagues entitled, "The Hepatitis C Virus (HCV) NS4B RNA [...]

Circadin is Approved in the EU for Treatment of Primary Insomnia in Patients Aged 55 or Over for up to 3 Months

TEL AVIV, Israel, July 5, 2010 – Neurim Pharmaceuticals (www.Neurim.com) confirmed today
that the European Commission (EC) has approved a change in treatment duration
with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the
treatment of primary insomnia in patients who are aged 55 or over.

The approval was based [...]

Finnish Pharmaceutical Innovation: Free Flowing Granulate

PDG Dry Granulation as Valid Alternative to Wet Granulation
HELSINKI, Finland, July 5, 2010 – Standard methods in pharmaceutical production often reach their
technological limits – be it wet granulation, roller compaction or direct
compression. The Finnish company Atacama Labs – www.atacamalabs.com -
with its proprietary pneumatic dry granulation technology extends this limit
successfully and provides free flowing granules [...]

Elsevier and International Society of Geriatric Oncology Launch Journal of Geriatric Oncology

New Journal Will Publish Research in the Developing Area of Geriatric Oncology

OXFORD, England, July 6, 2010 – Elsevier, the world-leading publisher of scientific, technical and
medical information products and services, and the International Society of
Geriatric Oncology (SIOG) announced today the launch of the Journal of
Geriatric Oncology (www.geriatriconcology.net). The journal is focused
on advancing research in the [...]

Helsinn and Mundipharma Sign New Contract for Palonosetron in Asian Countries

Helsinn's Second-Generation 5-HT3 RA Aloxi Expands its Presence in Asia Through the Agreement Signed With Mundipharma

LUGANO, Switzerland, July 6, 2010 – Helsinn Healthcare SA and Mundipharma International
Corporation Ltd. announce the signature of a Distribution and Licensing
Agreement for Helsinn's product palonosetron in Malesia, Philippines and
Singapore.
Aloxi(R) is a second generation 5-HT3 receptor [...]

EXCLAIM Study Publication in Annals of Internal Medicine Shows that Extended Anticoagulant Prophylaxis with Enoxaparin is Beneficial in Acutely Ill Medical Patients

Patients With Restricted Mobility, Elderly and Women Subgroups Drive the Patients' Benefit

NEW YORK, July 6, 2010 – The Steering Committee of the EXCLAIM study that explored the
benefit of extended prophylaxis of venous thrombo embolism (VTE) with
enoxaparin in acutely ill medical patients, announced today the publication
of the comprehensive study results in the peer-reviewed journal Annals [...]

NeuroFocus Reveals Groundbreaking Role That ‘Little Moments of Luxury’ Play in Economically Distressed Times, Introduces Luxury Perceptual Framework

New Methodology For Marketers Seeking Recessionary Solutions Measures Consumers' Subconscious Responses Across Eight Dimensions to Brands, Products, Packaging, In-Store Displays, Advertising, and Customer Service

BERKELEY, California, July 6, 2010 – As the economy sputters, the brain seeks relief in what the world's
leading neuromarketing company has identified as "little moments of luxury."
This finding lies at the [...]

Presentations at the Third European Stereotactic Radiation Therapy and Whole Body Radiotherapy Workshop Highlight Clinical Outcomes and Emerging Trends

Results Presented in Spine, Lung, Liver and Prostate Treatment Emphasized the Benefits of Whole Body Radiosurgery

SUNNYVALE, California, July 6, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
radiosurgery, today announced highlights from the Third European Stereotactic
Radiation Therapy and Whole Body Radiotherapy Workshop, held in Brussels,
Belgium on May 28 and May [...]

Design Award for Hitachi Medical Corporation Japan

ESSEN, Germany, July 6, 2010 – With its outstanding and innovative design, the HI VISION
Preirus, an ultrasound-based diagnostic imaging platform used to scan
internal body organs including the unborn baby, impressed the jury of one of
the most prestigious international design competitions. In the "red dot
award: product design 2010" the HI VISION Preirus ultrasound platform was
awarded [...]

Ground-Breaking Web Platform Revolutionizes Biomedical Research

BioHub-Online.org to Slash $1 Billion in Wasted Research Funds Through Community Networking

TORONTO, July 6, 2010 – BioHub Inc., announced today the launch of BioHub-Online.org, a first-of-
its-kind online platform to facilitate global networking and collaboration
among research scientists.
Antibodies are biomedical research reagents used for hundreds of
thousands of experiments globally. The global [...]

Knowledge Workers Divulge ‘Trade Secrets’ at Global Intelligence Forum

DUNGARVAN, Ireland, July 6, 2010 – What can the CIA learn from GE? What can a pediatric urologist
researching intersexuality learn from a forensic anthropologist working mass
disasters? All use "intelligence" in their own ways to make more informed
decisions, but rarely do they share with each other what works and what
doesn't.

Now, for [...]

New President and CEO Appointed at Ocean Nutrition Canada Limited

DARTMOUTH, Canada, July 6, 2010 – Ocean Nutrition Canada Limited – Long time Ocean Nutrition Canada Ltd.
(ONC) President and CEO, Robert Orr, will make way for a new CEO to lead the
company's next growth phase, with particular focus on international
expansion efforts and the food sector.

Martin Jamieson, a 30 year international [...]

Telemedicine Technology Market in Brazil, Russia, India, China (BRIC) Worth US $418.4 Million by the Year 2014

DALLAS, Texas, July 7, 2010 – According to the new market research report, "Telemedicine Market in
Brazil, Russia, India, China (BRIC) – Advanced technologies, Global Forecast"
published by MarketsandMarkets (www.marketsandmarkets.com), the BRIC
telemedicine is expected to reach a market size of $418.4 million by the year
2014, at a CAGR of 15.8% from 2009-2014. The BRIC telemedicine technology
market [...]

Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors

OXFORD, England, July 7, 2010 – Elsevier is pleased to announce the appointment of prominent new
Editors-in-Chief to three key endocrinology titles, effective immediately.

Editor-in-Chief, Metabolism: Christos S. Mantzoros, MD DSc FACP FACE
Christos Mantzoros is clinical research lead at the Department of
Endocrinology, Diabetes and Metabolism at Beth Israel [...]

Pioneering Use of Mobile Technology to Conduct Clinical Trials in Emerging Economies

BRUSSELS, July 7, 2010 – Last week, at the fourth annual Clinical Trials in Emerging Economies
conference, Margaret Ann Snowden, Director of Biostatistics and Data
Management at Aeras Global TB Vaccine Foundation, and Daragh Ryan of Cmed
Technology, presented a case study of the application of the latest in
clinical data technology to a large Phase II clinical [...]

2010 International Health Promotion Awards Symposium, Recognizing Innovative Health Programs Around the World, Scheduled for Rome, Italy, December 6-7, 2010

URAC and GKEN Seek Nominations at https://www.aihpa.org
WASHINGTON, July 7, 2010 – The inaugural International Health Promotion Awards Symposium
(www.aihpa.org), which recognizes and promotes innovative programs
that can significantly improve health around the world, will be held in Rome,
Italy on December 6-7, 2010.

(Logo: photos.prnewswire.com/prnh/20100422/URACLOGO)
Established by two leaders in health [...]

Cardiac Concepts Enrolls First Patients in Pilot Trial in Europe for the RespiCardia(TM) System

Trial Underway for the First Implantable System to Treat Heart Failure Patients with Central Sleep Apnea

MINNEAPOLIS, July 7, 2010 – Cardiac Concepts, Inc., a developer of medical devices to treat Heart
Failure patients who experience breathing disturbances during sleep,
announced today enrollment of the first European patients in a Pilot Clinical
Trial. The purpose of the Pilot [...]

REYATAZ(R) (atazanavir) Capsules Approved for Paediatric Use by The European Commission

PARIS, June 7, 2010 – Bristol-Myers Squibb announced that on 5th of July, the European
Commission has approved boosted REYATAZ(R) (atazanavir sulfate) capsules to
treat HIV-1 infection in paediatric patients aged six to eighteen years and
greater than 15 kg, as part of combination HIV therapy.(1) This decision
grants marketing authorisation in the 27 countries of the European [...]

InteRNA Technologies Announces Establishment of Scientific Advisory Board

UTRECHT, the Netherlands, July 8, 2010 – InteRNA Technologies B.V., a biopharmaceutical company focusing on the
development of intelligent microRNA (miRNA)-based therapeutics for cancer,
announces the establishment of its Scientific Advisory Board (SAB). The SAB
will further guide the Company in the development of cancer therapies based
on the unique functions of its proprietary miRNAs.

[...]

First English Vineyard to go Supercharged

Sometimes Known as Supercharged or Premium Organic, an East Sussex Vineyard is to be the First in England to Produce Wine Using Biodynamic Principles

SEDLESCOMBE, England, July 8, 2010 – Established 30 years ago as England's first organic wine producer Roy
Cook, owner and wine maker at Sedlescombe Vineyard, has taken the next step
in sustainability by [...]

Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States

AMSTERDAM, July 8, 2010 – Biopharmaceutical Company Kiadis Pharma announced today that it has
received approval for its Investigational New Drug (IND) application with the
US Food and Drug Administration (FDA) to start the pivotal clinical study for
its product ATIR(TM) in the United States. Kiadis Pharma is currently
enrolling patients in a multinational pivotal clinical study at [...]

Enrollment Underway in CLARITY-AF Study to Compare Efficacy, Safety and Efficiency of Two Catheter Ablation Technologies

WATERLOO, Belgium, July 8, 2010 – Biosense Webster, Inc., a worldwide leader in the diagnosis and
treatment of cardiac arrhythmias, announces that more than 10 patients have
now been enrolled in the CLARITY-study ("CLARITY-AF"), comparing the
efficacy, safety and efficiency of CARTO(R) 3 System guided radiofrequency
ablation using the NAVISTAR(R) THERMOCOOL(R) catheter versus fluoroscopy
guided radiofrequency ablation using the [...]

Unprecedented Donation Made by Mrs. Lily Safra to the Institute for Brain and Spinal Cord Disorders in Paris

PARIS, July 8, 2010 – Professor Gerard Saillant, President of the Institute for
Brain and Spinal Cord Disorders (ICM), announced today an unprecedented
donation of EUR8,000,000 from Mrs. Lily Safra. It is the largest single
donation made by a private individual to the ICM.

Professor Saillant will officially thank Mrs. Safra for this
generous donation [...]

arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform

Novel Platform Set to Transform Human Therapeutic Antibody Discovery & Development

ROTTERDAM, The Netherlands, July 8, 2010 – arGEN-X, a biopharmaceutical company focused on the discovery
and development of human monoclonal antibodies using its proprietary SIMPLE
Antibody(TM) platform, announces that it has been granted the first patent
covering the platform. The patent GB2461546B, has been granted by the [...]

New Report Patient Monitoring Emerging Markets (BRIC – Brazil, Russia, India and China) 2010 – 2014 Published by MarketsandMarkets

DALLAS, July 8, 2010 – According to a new market research report, 'Emerging Markets
BRIC (Brazil, Russia, India and China) Patient Monitoring Market (2010 -
2015), published by MarketsandMarkets (www.marketsandmarkets.com), the
total BRIC patient monitoring devices market is expected to be worth US$3,075
million by 2015, and the China market is expected to account for nearly 62.9%
of the [...]

Lialda(R) – Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.

DUBLIN and PHILADELPHIA, July 8, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its subsidiaries Shire Development
Inc. and Shire Pharmaceutical Development Inc. have filed a lawsuit in the
U.S. District Court for the District of Delaware against Cadila Healthcare
Limited, doing business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
(collectively [...]

New Reports on Cancer/Oncology Market July Update by MarketsandMarkets

DALLAS, July 8, 2010 – MarketsandMarkets published new market research reports in
Cancer/Oncology industry reports

Global Oncology Pharmaceuticals & Therapeutics Market (
www.marketsandmarkets.com/Market-Reports/oncology-pharmaceuticals-ther
apeutics-arket-152.html)

(Due to the length of these URLs, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one [...]

Elsevier and Legacy Interactive(R) Partner to Launch iPhone App for Medical Students, Residents and Faculty

Top Doc App Offers Interactive Medical Quizzes, Real World Applications
PHILADELPHIA, July 8, 2010 – Elsevier, a world leader in health care, medical publishing and online
solutions, and video game developer and publisher Legacy Interactive(R),
announced today the release of Top Doc, an iPhone app that features medical
content and quizzes designed to let medical students, residents and [...]

Boston Scientific Announces First Patient Enrollment in MultiSENSE Clinical Trial

NATICK, Massachusetts, July 8, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced
enrollment of the first patient in its MultiSENSE clinical trial. The trial
is designed to evaluate multiple physiologic sensors in the Company's
COGNIS(TM) cardiac resynchronization therapy defibrillators (CRT-Ds). Boston
Scientific plans to use the trial data to help develop a clinical alert that
identifies the early [...]

‘Include Veterinary Care in Holiday Plans,’ Advises the Royal College of Veterinary Surgeons

LONDON, July 8, 2010 – If you are holidaying with your pet this summer, remember to find out
about the arrangements for out-of-hours emergencies at a local veterinary
practice before you go, advises the Royal College of Veterinary Surgeons
(RCVS).

Veterinary surgeons across the UK are required under RCVS guidelines to
make provision for out-of-hours [...]

Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent

Second Recent Patent Issuance Related to Innovative Zamore 'Design Rules'

LONDON, July 7, 2010 – Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company")
announces the issuance of United States patent 7,750,144, titled Methods and
Compositions for Enhancing Efficacy and Specificity of RNA Silencing, by the
United States Patent and Trademark Office (USPTO). The issued patent
generally claims methods [...]

An Event in the Veterinary Community: REQUEST First Guidelines are now Available

PARIS, July 7, 2010 – REQUEST – a group of European veterinary experts in anti-infective
diseases – organised a specific session during the last WSAVA Congress in
Geneva, the 4th of June 2010.

To view the Multimedia News Release, please click:
multivu.prnewswire.com/mnr/prne/vetoquinol/42450/
The objective was to deliver [...]

Dementia Awareness Week

LONDON, July 7, 2010 – For this year's Dementia Awareness Week (4-10 July), journalist, author
and problem page editor, Virginia Ironside, is joining up with national care
provider, Barchester Healthcare, and Alzheimer's Society to launch some new
children's books!

'Visiting Grandad's new home' and 'Visiting Gran's new home' are
original, brand-new and beautifully illustrated books, [...]

Telemedicine Technology Market in Brazil, Russia, India, China (BRIC) Worth US $418.4 Million by the Year 2014

DALLAS, Texas, July 7, 2010 – According to the new market research report, "Telemedicine Market in
Brazil, Russia, India, China (BRIC) – Advanced technologies, Global Forecast"
published by MarketsandMarkets (www.marketsandmarkets.com), the BRIC
telemedicine is expected to reach a market size of $418.4 million by the year
2014, at a CAGR of 15.8% from 2009-2014. The BRIC telemedicine technology
market [...]

Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors

OXFORD, England, July 7, 2010 – Elsevier is pleased to announce the appointment of prominent new
Editors-in-Chief to three key endocrinology titles, effective immediately.

Editor-in-Chief, Metabolism: Christos S. Mantzoros, MD DSc FACP FACE
Christos Mantzoros is clinical research lead at the Department of
Endocrinology, Diabetes and Metabolism at Beth Israel [...]

Pioneering Use of Mobile Technology to Conduct Clinical Trials in Emerging Economies

BRUSSELS, July 7, 2010 – Last week, at the fourth annual Clinical Trials in Emerging Economies
conference, Margaret Ann Snowden, Director of Biostatistics and Data
Management at Aeras Global TB Vaccine Foundation, and Daragh Ryan of Cmed
Technology, presented a case study of the application of the latest in
clinical data technology to a large Phase II clinical [...]

2010 International Health Promotion Awards Symposium, Recognizing Innovative Health Programs Around the World, Scheduled for Rome, Italy, December 6-7, 2010

URAC and GKEN Seek Nominations at https://www.aihpa.org
WASHINGTON, July 7, 2010 – The inaugural International Health Promotion Awards Symposium
(www.aihpa.org), which recognizes and promotes innovative programs
that can significantly improve health around the world, will be held in Rome,
Italy on December 6-7, 2010.

(Logo: photos.prnewswire.com/prnh/20100422/URACLOGO)
Established by two leaders in health [...]

Cardiac Concepts Enrolls First Patients in Pilot Trial in Europe for the RespiCardia(TM) System

Trial Underway for the First Implantable System to Treat Heart Failure Patients with Central Sleep Apnea

MINNEAPOLIS, July 7, 2010 – Cardiac Concepts, Inc., a developer of medical devices to treat Heart
Failure patients who experience breathing disturbances during sleep,
announced today enrollment of the first European patients in a Pilot Clinical
Trial. The purpose of the Pilot [...]

REYATAZ(R) (atazanavir) Capsules Approved for Paediatric Use by The European Commission

PARIS, June 7, 2010 – Bristol-Myers Squibb announced that on 5th of July, the European
Commission has approved boosted REYATAZ(R) (atazanavir sulfate) capsules to
treat HIV-1 infection in paediatric patients aged six to eighteen years and
greater than 15 kg, as part of combination HIV therapy.(1) This decision
grants marketing authorisation in the 27 countries of the European [...]

De La Rue Provides Second-Generation ePassport for Malta

LONDON, July 6, 2010 – De La Rue Identity Systems, a world expert in secure government identity
solutions, announced that Malta's new upgraded ePassport system with Extended
Access Control (EAC) capability went live on 28th June. This new solution
delivers a higher level of security and access control, in accordance with
the EU regulation for all Schengen Member [...]

Tackling the Growing Obesity Epidemic: New Research Shows Weight Watchers Works Globally

STOCKHOLM, July 13, 2010 – New research unveiled at the International Congress on Obesity (ICO) is
further evidence of how Weight Watchers helps people around the world lose
weight effectively, and has the potential to collaborate further with public
health care providers worldwide to help reverse the obesity epidemic.

"New research in countries as [...]

Roche Obtains Co-Exclusive License to Develop PCR Assays Detecting Mutations in the PI3K Oncogene

PLEASANTON, California, July 13, 2010 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the company has
obtained a worldwide co-exclusive license for the biomarker PI3K
(phosphoinositide 3-kinase) from QIAGEN to develop real-time and endpoint PCR
diagnostic assays. Johns Hopkins University owns the patent for the PI3K
biomarker and has previously granted an exclusive license to QIAGEN's [...]

Animal Airways Establishes First Flight Veterinarian Division

LONDON, July 12, 2010 – Animal Airways, the global pet flight & relocation provider, leads a new
approach to shipping pets overseas: an international flight veterinarian
division operating 24/7 worldwide in order to ensure pets safety & well-being
throughout the flight process.

Flying and relocating with pets on a global level involves
veterinarian support for [...]

The Biology of Fungi – 1.5 Million Species – 1 Congress

1700 Delegates to Meet at the 9th Mycological Congress 1-6 August 2010, Edinburgh

OXFORD, England, July 12, 2010 – The British Mycological Society, in association with Elsevier, the
world-leading publisher of scientific, technical and medical information,
today announced the final programme for the 9th Mycological Congress IMC9:
The Biology of Fungi. This congress takes place every 4 years [...]

Buenos Aires Welcomes CPhI South America 2010

AMSTERDAM, July 12, 2010 – According to leading global business media company UBM International
Media, Argentina promises to deliver a productive experience for CPhI South
America 2010, the company's world leading pharmaceutical ingredients and
services event. Taking place from August 17-19 at La Rural – Hall Ocre in
Buenos Aires, Argentina, CPhI South America is joined for the [...]

Ocean Nutrition Canada Announces Acquisition of Exclusive License to GAT Food Essentials, Omega-3 Microencapsulation-Emulsion Technology

DARTMOUTH, Canada, July 12, 2010 – Ocean Nutrition Canada (ONC) supplier of the most trusted source of
Omega-3, EPA/DHA, food and dietary supplement ingredients, announces today
the acquisition of the exclusive global marketing and distribution rights to
GAT Food Essentials (GAT) Omega-3 microencapsulation-emulsion technology.

As a result of the agreement, ONC acquired the rights [...]

Sheffield Bio-Science Wins 2010 Lilly Global Supplier Award

BELOIT, Wisconsin, July 12, 2010 – Sheffield Bio-Science, a leading global pharmaceutical supplier of
superior quality cell nutrition and excipient products for the biotech and
pharmaceutical markets, has been awarded the distinguished 2010 Lilly Global
Supplier Award.

The Lilly Global Supplier Award recognizes Sheffield Bio-Sciences'
consistent execution of quality and services for Eli Lilly and [...]

Signum Biosciences, Inc. Announces Commercial Launch of Arazine(TM)

Proprietary skincare technology platform reaches market
PRINCETON, New Jersey, July 13, 2010 – Signum Biosciences announced that its partner, Rohto Pharmaceutical Co.,
Ltd., has launched AFC Medirepair(R) with Signum's compound Arazine(TM)
(n-acetyl-s-farnsylcysteine or AFC) in Japan. Arazine(TM) is the first
compound from Signum's novel anti-inflammatory platform to be commercialized
from Signum's pipeline of Signal Transduction Modulators (STMs). The DRx [...]

MarketsandMarkets: Global Dental Implants Market Worth US$4.2 Billion by 2015

DALLAS, July 13, 2010 – According to the new market research report, "Global Dental Implants
Market" published by MarketsandMarkets (www.marketsandmarkets.com),
the global dental implants market is worth approximately $3.2 billion in 2010
and expected to reach $4.2 billion in 2015 at an estimated CAGR of 6.0% from
2010 to 2015. The European market is expected to account for [...]

Essilor Cancels Four Million Shares

CHARENTON-LE-PONT, France, July 13, 2010 – On June 28, 2010, Essilor cancelled 4,000,000 shares, in line with its
commitment not to create any dilution for existing shareholders. The two-part
transaction was carried out as follows:

– 2,130,000 shares were cancelled to offset the dilutive impact of the
vesting [...]

Objet and 3Shape Join Forces to Offer Dental Labs a Seamless CAD/CAM Design-to-Production Solution

REHOVOT, Israel and COPENHAGEN, July 13, 2010 – Objet Geometries (www.objet.com/), the innovation leader in 3D
printing, together with 3Shape A/S, a global leader in 3D scanners and
CAD/CAM software solutions for the Dental Industry, today announced the
availability of a jointly developed solution that integrates with the 3Shape
Dental System(TM) 2010, enabling its 3D restoration designs to [...]

Nanotechnology R&D Grows in Beauty Industry According to Thomson Reuters Intellectual Property Analysis

Global study shows growth in nanotechnology-based personal care products and brands

EAGAN, Minnesota, July 13, 2010 – Small particles are becoming a big business for the world's personal care
products manufacturers according to an analysis of world patent activity
published today by the IP Solutions business of Thomson Reuters. The new
report, Can Nanotech Unlock the Fountain of [...]

First Complete Surgical System Specifically Designed to Treat Progressive Osteoarthritis of the Knee is Launched in Europe

LEEDS, England, July 13, 2010 – DePuy Orthopaedics EMEA today announces the introduction of
Sigma(R) High Performance Partial Knee, the only partial knee replacement
system designed to provide the complete solution to progressive
osteoarthritis in active patients.

Until now, orthopaedic surgeons have had limited options for
the treatment of progressive degradation of the knee joints [...]

Elsevier Expands Publishing Operation in Saudi Arabia in Collaboration With Key University

MADRID, July 13, 2010 – King Saud University and Elsevier have signed an agreement to provide
access to a series of scholarly journals from Saudi Arabia, improving and
accelerating the dissemination of research from this increasingly important
region.

Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, is pleased to announce [...]

Increased Need for Remote Patient Monitoring Drives the Data Management Systems for Patient Monitoring Markets in Europe, Finds Frost & Sullivan

LONDON, July 14, 2010 – The increased need for real-time data management and the improved
receptiveness of a technology to monitor patients effectively are driving the
markets for data management systems (DMS) for patient monitoring in Europe.
The participants are looking for options that allow physicians to manage the
massive data collected and help reduce errors caused by [...]

Varian Selects Varicent to Enhance Forecasting Capabilities and to Manage Complex Incentive Compensation Requirements

Varicent increases medical device industry penetration with the addition of Varian Medical Systems to their expanding customer base

TORONTO, July 14, 2010 – Varicent Software Incorporated, the leading innovator in incentive
compensation (ICM) and sales performance management (SPM) solutions,
announced today that a business unit within Varian Medical Systems, the
world's leading manufacturer of medical devices and software [...]

Oncura(TM) Announces Exclusive Supply and Resale Agreement With Theragenics Corporation

CHICAGO, July 14, 2010 – ONCURA, a business unit of GE Healthcare and global leader in the
minimally invasive permanent prostate brachytherapy management of prostate
cancer, has announced that it has signed an agreement to distribute
Theragenics Corporation TheraSeed(R) palladium-103 brachytherapy seeds.

Under the terms of the agreement, Oncura will exclusively sell
the TheraSeed palladium-103 [...]

Award Winning Mayo Clinic Scientist Joins Cardio3 BioSciences

Dr. Atta Behfar Recognised With Prestigious Award for Science Behind Cardio3 BioSciences' C-Cure Technology

MONT-SAINT-GUIBERT, Belgium, July 14, 2010 – Cardio3 BioSciences, a leading Belgian biotechnology company specialising
in regenerative therapies for the treatment of cardiovascular diseases, today
announces that Dr. Atta Behfar is joining its research and development
laboratories as Director for Advanced Research. Dr. Atta Behfar, [...]

BARRX Medical, Inc. Completes US$15 Million Growth Financing

Investment will be used to significantly expand the utilization of the HALO technology in new disease states and new international markets

SUNNYVALE, California, July 14, 2010 – BARRX Medical, Inc. today announced the closing of a US$15 million Series
D financing, which was led by new investor Highland Capital Partners and
joined by existing investors Delphi Ventures, [...]

MarketsandMarkets: Patient Monitoring Devices Markets in Brazil, Russia, India and China Worth $2,992 Million by 2015

DALLAS, July 14, 2010 – According to a new market research report, 'Patient Monitoring
Devices – Emerging Markets BRIC (Brazil, Russia, India and China) 2010-2015,
published by MarketsandMarkets (www.marketsandmarkets.com), the BRIC
patient monitoring market is expected to be worth $2,992 million by 2015,
with China accounting for nearly 62.9% of the total revenues.

Browse in-depth [...]

Varicent to Provide Global Eye Care Leader Alcon With Global Solution for Sales Performance Management

Varicent expected to enhance sales performance management functionality for multiple geographic business units

TORONTO, July 15, 2010 – Varicent Software Incorporated, the leading innovator in incentive
compensation (ICM) and sales performance management (SPM) solutions,
announced today that it will provide its innovative solutions to Alcon, the
world's largest eye-care company.
Alcon Japan recently chose Varicent [...]

Frost & Sullivan Recognizes Camozzi spa for Outstanding Customer Service in the Western European Pneumatic Valves Market

LONDON, July 15, 2010 – Based on its recent research on the pneumatic valves market, Frost &
Sullivan presents Camozzi spa with the "2010 Western European Customer
Service Leadership Award." The mature and consolidated pneumatic valves
market in Western Europe requires manufacturers to excel in the area of
customer service for gaining a competitive edge. Camozzi spa has [...]

Second Quarter 2010 Results Date Notification – August 4, 2010

DUBLIN, July 15, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, will announce second quarter 2010 earnings on
Wednesday August 4, 2010.

Results press release will be issued at: 12:00 BST / 07:00 EDT
Investor conference call time: [...]

JuvoLab Announces Results of Study Analyzing Entire Global Oncology Community’s Twitter Usage at ASCO 2010

First-ever aggregate analysis of physician, pharmaceutical and biotechnology industry, academic association, institution, journal, marketing and communications industry, non-profit organization, and patient advocate social media usage to discuss and disseminate breaking data and conduct compliant corporate promotion at the 2010 American Society of Clinical Oncology Annual Meeting (ASCO) released today

NEW YORK, July 15, 2010 – [...]

Agendia to Provide Testimony at Public Meeting on FDA Oversight of Laboratory-Developed Tests

World Leader in Cancer Diagnostics Joins Nation's Top Safety Agency in Calling for Risk-Based Oversight of Genomic Testing

IRVINE, California, and AMSTERDAM, July 15, 2010 – Agendia, a world leader in molecular cancer diagnostics, announced today
that company CEO Dr. Bernhard Sixt will provide testimony at a public meeting
on July 20 in Washington D.C. on the [...]

David Moreira Appointed Vice President of Marketing, Menicon America

NAGOYA, Japan, July 20, 2010 – -Menicon focusing on expanding its presence in the custom contact lens
market-

Menicon Co., Ltd. announced on July 20 the appointment of David Moreira
as Vice President of Marketing for Menicon America Inc. Moreira will report
to Jonathan Jacobson, President of Menicon America.
Moreira joins [...]

World’s Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients

ZURICH, July 19, 2010 – Today, Novo Nordisk announced the landmark recruitment of the 60,000th
patient in the A1chieve(R) study – an observational study designed to
investigate the effects of modern insulins in the management of type 2
diabetes.[1]

Spanning 28 countries across 4 continents and involving more than 3300
physicians, A1chieve(R) is set to [...]

Visage Imaging Releases Amira 5.3

Introducing a new powerful toolset for Neuroscience and a multitude of new features and improvements

SAN DIEGO, California, July 19, 2010 – Visage Imaging(R), Inc., a wholly owned subsidiary of Pro Medicus Ltd.
(ASX: PME), is pleased to announce the immediate release of Amira 5.3, a new
major version of its market-leading software platform for visualizing,
analyzing, and [...]

Abbott’s PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint

PROGRESS is the First Study to Present 48-Week Efficacy Results for this Combination When Used in Treatment-Naive Patients with HIV

VIENNA, July 19, 2010 – Abbott (NYSE: ABT) today presented 48-week findings comparing an HIV
regimen of its protease inhibitor (PI), Kaletra(R) (lopinavir/ritonavir), and
Merck's integrase inhibitor, Isentress(R) (raltegravir), to a traditional HIV
regimen of Kaletra and the [...]

Bill Gates: World Has Historic Opportunity to ‘Change the Face of AIDS’

In Keynote Speech to AIDS Conference, Gates Outlines Roadmap to Reduce Annual New HIV Infections 90% by 2031

VIENNA, July 19, 2010 – Speaking to the 18th International AIDS Conference today, Bill Gates
called on all countries to keep up the fight against HIV/AIDS, saying the
world has an historic opportunity to "change the face of AIDS." [...]

Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance

Terms include initial US$1.25 million ELITech equity investment in Corgenix with options for US$3 million total, plus distribution agreement and diagnostic system co-development

DENVER and PARIS, July 19, 2010 – Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide
developer and marketer of diagnostic test kits, and the ELITech Group, a
Paris, France-based, privately held group of [...]

Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program

SAN DIEGO, July 19, 2010 – "Amira Pharmaceuticals, Inc. announced today that its FLAP
(5-lipoxygenase-activating protein) program, which is partnered with
GlaxoSmithKline, has achieved two clinical development milestones."

These milestones are related to the successful progression of the program
to Phase 2 studies, which explore the use of the Amira discovered FLAP
inhibitor in patients [...]

International Organizations Agree to Take Concerted Action to End Pediatric HIV/AIDS

"No child should enter this world infected with HIV."
VIENNA, July 19, 2010 – A global alliance of international organizations, including the heads of
UNICEF, UNAIDS and The Global Fund to Fight AIDS, Tuberculosis and Malaria as
well as other NGOs including the Pan African Treatment Access Movement,
Health GAP, Ugandan Pediatric Association and the Global AIDS Alliance [...]

ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina

Paper Highlights the Potential of Microplasmin for Nonsurgical Treatment of Vitreomacular Adhesion

LEUVEN, Belgium, July 15, 2010 – ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical
company focused on the discovery and development of innovative treatments for
eye disease, vascular disease and cancer, announces today that positive
microplasmin Phase II trial results, evaluating the product for the
nonsurgical treatment of [...]

Oasmia Pharmaceutical AB, Sweden – Listing Prospectus: NASDAQ OMX Stockholm

A Number of Promising New Product Candidates for Cancer Treatment, Within Both Human and Veterinary Oncology

UPPSALA, Sweden, July 15, 2010 – ABOUT OASMIA
Oasmia is developing a new generation of drugs with emphasis
on human and veterinary oncology. Our main business activity focuses on
improving product life cycles and the versatility of current [...]

New Psoriasis eCommerce Shop Launched by PAPAA

ST ALBANS, England, July 15, 2010 – The Psoriasis and Psoriatic Arthritis Alliance (PAPAA) has launched a new
secure eCommerce site www.psoriasis-shop.org . Visitors can now order
free information, pay and renew their subscription, make donations and buy
from a selection of publications aimed at providing practical information on
these conditions.

A spokesperson for the [...]

Varicent to Provide Global Eye Care Leader Alcon With Global Solution for Sales Performance Management

Varicent expected to enhance sales performance management functionality for multiple geographic business units

TORONTO, July 15, 2010 – Varicent Software Incorporated, the leading innovator in incentive
compensation (ICM) and sales performance management (SPM) solutions,
announced today that it will provide its innovative solutions to Alcon, the
world's largest eye-care company.
Alcon Japan recently chose Varicent [...]

Frost & Sullivan Recognizes Camozzi spa for Outstanding Customer Service in the Western European Pneumatic Valves Market

LONDON, July 15, 2010 – Based on its recent research on the pneumatic valves market, Frost &
Sullivan presents Camozzi spa with the "2010 Western European Customer
Service Leadership Award." The mature and consolidated pneumatic valves
market in Western Europe requires manufacturers to excel in the area of
customer service for gaining a competitive edge. Camozzi spa has [...]

Second Quarter 2010 Results Date Notification – August 4, 2010

DUBLIN, July 15, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, will announce second quarter 2010 earnings on
Wednesday August 4, 2010.

Results press release will be issued at: 12:00 BST / 07:00 EDT
Investor conference call time: [...]

JuvoLab Announces Results of Study Analyzing Entire Global Oncology Community’s Twitter Usage at ASCO 2010

First-ever aggregate analysis of physician, pharmaceutical and biotechnology industry, academic association, institution, journal, marketing and communications industry, non-profit organization, and patient advocate social media usage to discuss and disseminate breaking data and conduct compliant corporate promotion at the 2010 American Society of Clinical Oncology Annual Meeting (ASCO) released today

NEW YORK, July 15, 2010 – [...]

Agendia to Provide Testimony at Public Meeting on FDA Oversight of Laboratory-Developed Tests

World Leader in Cancer Diagnostics Joins Nation's Top Safety Agency in Calling for Risk-Based Oversight of Genomic Testing

IRVINE, California, and AMSTERDAM, July 15, 2010 – Agendia, a world leader in molecular cancer diagnostics, announced today
that company CEO Dr. Bernhard Sixt will provide testimony at a public meeting
on July 20 in Washington D.C. on the [...]

NEXUS Biosystems Acquires Tecan Group’s REMP Sample Management Business

POWAY, California, July 15, 2010 – NEXUS Biosystems, Inc., a leading innovator and worldwide provider of
automated sample management systems, today announced the signing of an
agreement to acquire REMP AG, a wholly-owned subsidiary of Tecan, as well as
other related assets. Under this agreement, NEXUS will acquire all activities
of Tecan's REMP(R) Sample Management business segment from [...]

Substantial Revenues and Earnings Plus for Gerresheimer

D??SSELDORF, Germany, July 14, 2010 -

– Group Revenues in the Second Quarter up by 6.8% (Excluding
Technical Plastic Systems)

– Further Solid Growth of the Pharma Business – Improvement in
the Cosmetics and Life Science Research Segments

[...]

New Procedures Consult Mobile From Elsevier Enables Clinicians to View Top Medical Procedures From Mobile Devices

Physicians, Residents and Students now Able to Prepare, Review and Test Knowledge of Common Medical Procedures Anywhere, Anytime

PHILADELPHIA, Pennsylvania, July 14, 2010 – Elsevier, the world's leading publisher of scientific, technical, and
medical information products and services, announced today that physicians,
residents and students will be able to visualize and review over 300 top
medical procedures on [...]

Increased Need for Remote Patient Monitoring Drives the Data Management Systems for Patient Monitoring Markets in Europe, Finds Frost & Sullivan

LONDON, July 14, 2010 – The increased need for real-time data management and the improved
receptiveness of a technology to monitor patients effectively are driving the
markets for data management systems (DMS) for patient monitoring in Europe.
The participants are looking for options that allow physicians to manage the
massive data collected and help reduce errors caused by [...]

David Moreira Appointed Vice President of Marketing, Menicon America

NAGOYA, Japan, July 20, 2010 – -Menicon focusing on expanding its presence in the custom contact lens
market-

Menicon Co., Ltd. announced on July 20 the appointment of David Moreira
as Vice President of Marketing for Menicon America Inc. Moreira will report
to Jonathan Jacobson, President of Menicon America.
Moreira joins [...]

Bristol-Myers Squibb Foundation’s SECURE THE FUTURE(R) Works to Reduce the Impact of HIV and Tuberculosis Epidemic in Africa

Community-Based Programs Confront Challenges Associated With Dual Epidemic -

VIENNA, July 20, 2010 – Bristol-Myers Squibb Company (NYSE: BMY) and the Bristol-Myers Squibb
Foundation announced at the XVIII International AIDS Conference in Vienna the
community-based projects that it is currently supporting in resource-poor
regions across Africa to help combat the challenge of HIV and tuberculosis
co-infection.
[...]

Frost & Sullivan: Consumers Becoming Increasingly Savvy About Marine and Algae Oil Omega-3 Ingredients

LONDON, July 20, 2010 – The flood of scientific evidence on omega-3 eicosapentaenoic
acid/docosahexaenoic acid (EPA/DHA) has significantly buoyed the credibility
of polyunsaturated fatty acids (PUFAs) as vital functional ingredients.
Heightened consumer awareness has had a telling effect on the healthy growth
charts of the marine and algae oil omega-3 ingredients market.

(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
[...]

Operational Agility Forum Launched – New Thought Leadership Forum to Focus on the Challenge of Achieving Agility in Business Operations

Senior IT and Business Professionals Create New Forum to Focus on the Challenge of Achieving Operational Agility

LONDON, July 20, 2010 – A new interest group called the Operational Agility Forum has been
established by senior information technology and business professionals who
represent some of the largest users of IT in the UK. Members of the forum
work [...]

PSI and Partners Join Call for Male Circumcision Scale Up

WHO, US Global AIDS Coordinator, and noted academic highlight ways to maximize impact of the life-saving intervention at the International AIDS Conference in Vienna

VIENNA, July 20, 2010 – The U.S. Global AIDS Coordinator Ambassador Eric Goosby and the World
Health Organization's Director of HIV, TB, and Malaria, Africa Regional
Office, Dr. David Okello, joined PSI (Population [...]

ARUP Laboratories Ink Partnership to Offer deCODE ProstateCancer(TM) Test

U.S. Laboratories and Physicians Will be Able to use Their ARUP Accounts to Order deCODE's Test for Assessing Risk of Prostate Cancer

Reykjavik, ICELAND, and Salt Lake City, UTAH, July 20, 2010 – deCODE genetics and ARUP Laboratories today announced a partnership
through which ARUP will offer deCODE's DNA-based prostate cancer risk
assessment test to its clients [...]

Health Robotics’ CytoCare Continues European Expansion With Grifols and Vall d’Hebron University Hospital

BOZEN, Sud-Tirol, Italy, July 20, 2010 – Health Robotics today announced that it recently signed agreements to
grant exclusive CytoCare distribution rights in Spain and Portugal to
world-leading IV Therapy company Grifols S.A., and to install the first-ever
Cancer Therapy Robot in Spain at Vall d'Hebron University Hospital in
Barcelona in November 2010.

"We are [...]

MEDcounselor Drug Information Now Available on ISMP’s ConsumerMedSafety.org

MEDcounselor's Drug Information, Drug IDentifier and Drug Interactions Modules Help Consumers Take Medications Safely, Avoid Errors

TAMPA, Florida, July 20, 2010 – Gold Standard/Elsevier, developer of drug information and
medication management solutions, announced today that the Institute for Safe
Medication Practices (ISMP) has licensed MEDcounselor (
www.goldstandard.com/pages/medCounselor.html?epm=1_1) Drug
Information, Drug IDentifer and Drug Interaction modules for its consumer
website, ConsumerMedSafety.org [...]

MarketsandMarkets Partners With Centre of Business Intelligence (CBI) for its Market Research and Product Forecasting Summit

DALLAS, July 20, 2010 – Event Date- July 26 – 27, 2010

Location- Philadelphia, PA
About the event:
Join your colleagues and peers to discuss optimizing, executing and
improving market research to drive accurate sales forecasting. This is a
unique opportunity for pharmaceutical executives to hear best [...]

Abbott’s PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint

PROGRESS is the First Study to Present 48-Week Efficacy Results for this Combination When Used in Treatment-Naive Patients with HIV

VIENNA, July 19, 2010 – Abbott (NYSE: ABT) today presented 48-week findings comparing an HIV
regimen of its protease inhibitor (PI), Kaletra(R) (lopinavir/ritonavir), and
Merck's integrase inhibitor, Isentress(R) (raltegravir), to a traditional HIV
regimen of Kaletra and the [...]

Bill Gates: World Has Historic Opportunity to ‘Change the Face of AIDS’

In Keynote Speech to AIDS Conference, Gates Outlines Roadmap to Reduce Annual New HIV Infections 90% by 2031

VIENNA, July 19, 2010 – Speaking to the 18th International AIDS Conference today, Bill Gates
called on all countries to keep up the fight against HIV/AIDS, saying the
world has an historic opportunity to "change the face of AIDS." [...]

Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance

Terms include initial US$1.25 million ELITech equity investment in Corgenix with options for US$3 million total, plus distribution agreement and diagnostic system co-development

DENVER and PARIS, July 19, 2010 – Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide
developer and marketer of diagnostic test kits, and the ELITech Group, a
Paris, France-based, privately held group of [...]

Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program

SAN DIEGO, July 19, 2010 – "Amira Pharmaceuticals, Inc. announced today that its FLAP
(5-lipoxygenase-activating protein) program, which is partnered with
GlaxoSmithKline, has achieved two clinical development milestones."

These milestones are related to the successful progression of the program
to Phase 2 studies, which explore the use of the Amira discovered FLAP
inhibitor in patients [...]

International Organizations Agree to Take Concerted Action to End Pediatric HIV/AIDS

"No child should enter this world infected with HIV."
VIENNA, July 19, 2010 – A global alliance of international organizations, including the heads of
UNICEF, UNAIDS and The Global Fund to Fight AIDS, Tuberculosis and Malaria as
well as other NGOs including the Pan African Treatment Access Movement,
Health GAP, Ugandan Pediatric Association and the Global AIDS Alliance [...]

MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014

DALLAS, July 21, 2010 – According to the new market research report "Bioinformatics Market -
Advanced Technologies, Global Forecast and Winning Imperatives (2009-2014)",
published by MarketsandMarkets (www.marketsandmarkets.com), the global
bioinformatics market is expected to reach a $8.3 billion by 2014 at a high
CAGR of 24.8% from 2009-2014. While knowledge management formed the largest
submarket is 2009 at $1.3 [...]

Eye Care Company Leader Alcon Japan Ltd. Goes Live With Varicent to Automate Their Incentive Compensation System

Varicent solution to enable modeling and forecasting functionality as well as business ownership

TORONTO, July 21, 2010 – The leading innovator in incentive compensation (ICM) and sales
performance management (SPM) solutions, Varicent Software Incorporated,
announced today a successful "go live" of Varicent for Alcon Japan Ltd.
After a thorough survey of SPM products, Alcon [...]

Concentric Medical Announces First Stroke Patients Treated With the Merci Retriever(R) in Japan

MOUNTAIN VIEW, California, July 21, 2010 – Concentric Medical, Inc., the global leader in devices for clot removal
in acute ischemic stroke patients, today announced the treatment of the first
patient in Japan with the Merci Retriever(R). The Merci Retriever is a
catheter-based medical device that stroke centers use to remove blood clots
from the brains of patients [...]

Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2010

ABBOTT PARK, Illinois, July 21, 2010 -

– Second Quarter Ongoing EPS Growth of 13.5 Percent -
– Worldwide Sales Increased 17.8 Percent -
– Strong Performance Across Diverse Businesses -
– Accelerated Emerging Markets Leadership -
– Enhanced [...]

GlaxoSmithKline CEO Interviewed On Half-Year and Q2 Results

LONDON, July 21, 2010 – In an interview with financial broadcaster www.cantos.com,
GlaxoSmithKline CEO Andrew Witty says one-offs held back sales growth in Q2
but highlights the strong underlying performance of Emerging Markets,
Consumer and Vaccines.

The Pharma boss also points to "an unprecedented" five new drugs in late
stage trials as a sign of [...]

Netter Products Expand Offerings to Include Interactive Online and Mobile Technologies

Medicine's Most Well Known Anatomy Products Offer Students and Medical Professionals Online and Mobile Tools to aid Learning and Review

PHILADELPHIA, July 21, 2010 – Netter Products (www.netterimages.com/), which are based on
medicine's most well known and comprehensive collection of hand-painted
anatomy illustrations by Frank Netter, M.D, have evolved into sophisticated
digital tools that aid students and clinicians [...]

Largest U.S. Surrogacy Agency Traveling to London to Host Private Consultations – Agency Now Offering the First Ever Surrogacy Financing Program

LOS ANGELES, July 22, 2010 – Since 1996, Growing Generations has been a company passionately dedicated
to the vision of creating life and, in the process, changing the world. Its
mission is simple – to build families of choice for all communities through
surrogacy, egg donation, and sperm donation. To build on this mission,
Growing Generations is excited [...]

London Genetics Expands its Senior Advisory Team

LONDON, July 22, 2010 – London Genetics Limited, an expert in the use of pharmacogenetics in
clinical drug discovery and development, is pleased to announce that it
has augmented the strength of its team with the appointment of two senior
advisers, Professors Stephen DeCherney and Munir Pirmohamed. With their
extensive clinical, healthcare, and drug development expertise, their
guidance will [...]

Lost and Found: L2FU Recovers 100% of Clinical Trial Patients for Recent Pivotal Study

Patients 'lost' from a clinical trial result in study delays, increased patient recruitment costs and compromised study data. L2FU provides critical solutions.

KING OF PRUSSIA, Pennsylvania, July 22, 2010 – Recovering unnecessarily lost patient information is now a viable
reality. Lost to follow up (L2FU) rates in clinical research trials can range
from 20- 60%. As a [...]

Frost & Sullivan Lauds RF Co., Ltd. for Its Groundbreaking Digital Radiography Products

LONDON, July 27, 2010 – Based on its recent research on the digital radiography market, Frost &
Sullivan presents RF Co., Ltd. with the "2010 European Medical Technologies
Product Leadership of the Year Award," for NAOMI, a digital x-ray sensor that
does not require any film development to acquire x-ray film images.

(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
[...]

QPS Announces the Acquisition of Xendo Drug Development

This European Acquisition Expands QPS' Global Capabilities
NEWARK, Delaware and GRONINGEN, Netherlands, July 26, 2010 – QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract
research organization providing testing services to support preclinical and
clinical research and development, announced the completion of its
acquisition of Xendo Drug Development BV (XDD), headquartered in Groningen,
The Netherlands. XDD, a European contract research [...]

Will Anyone be Normal?

Diagnosis and the DSM-5: Proposed Changes to Diagnostic Best Practice Offer a Staggering Range of 'New' Conditions. Sir Terry Pratchett and Others Weigh in on the Impact of Mental Health Diagnosis and the Ever-Shrinking Idea of Normalcy

LONDON, July 27, 2010 – This month Journal of Mental Health features a special issue on
diagnosing mental illness. [...]

Animal Experiments Statistics Total 3.6 Million – “a Shameful Legacy of Science’s Complacency About Animal Suffering”

Humane Society International has reacted strongly to Home Office statistics released today revealing no significant decrease in animal experiments conducted in Britain, still totalling 3.6 million experiments in 2009

LONDON, July 27, 2010 – The Home Office emphasises that most procedures were on rodents (82
percent), but HSI research (see below) reveals mice and rats often [...]

Health Robotics Surpasses 100 Installations Milestone and Acquires Two I.V. Room of the Future Partner Companies

BOZEN, SUD-TIROL, Italy, July 27, 2010 – Health Robotics announced that it has reached final agreements to acquire
all assets from Italy-based MEDarchiver S.r.l. and Biomedical Technology
Consulting S.r.l., merging these companies' employees and operations,
re-entering direct sales activities in the Italian market, and conducting a
re-organization of its Executive Management, expecting to close these
acquisitions over the next [...]

Hospitals in India Experience Downward Pricing

SEBASTIAN, Florida, July 27, 2010 – This month, as predicted in the February 2008 issue of the PHM Emerging
Markets Healthcare Monitor, insurance companies in India announced that they
would only work with hospitals that meet their pricing demands. These firms
control nearly 70% of the Indian health insurance market.

Hank Kearney, president of [...]

Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe

EMERYVILLE, California, July 29, 2010 – Bionovo, Inc. (Nasdaq: BNVI) announced today that it has received final
guidance from the European Medicines Agency (EMA) in order to advance
Menerba, the company's lead drug candidate for menopausal symptoms, to Phase
3 clinical trials in Europe. The guidance defines the clinical and regulatory
pathway to a European marketing authorization for [...]

Simbionix Continues its Global Expansion

CLEVELAND, Ohio, July 28, 2010 – Simbionix USA Corporation, the world's leading provider of medical
education and simulation training products for medical professionals and the
healthcare industry, is pleased to announce the company's continued global
expansion. Simbionix has increased the size of two of its major facilities
with an expansion of its Corporate Headquarters in Cleveland, OH, and [...]

Liquent Unveils the Results of its Regulatory Affairs Trends Survey

Regulatory Professionals Contribute to this Global Insight into Regulatory Trends

HORSHAM, Pennsylvania, July 28, 2010 – Liquent, Inc. ("Liquent") is pleased to announce the findings of its 2009
Liquent Regulatory Affairs Trends Survey. The survey attracted respondents
from across the globe representing small, medium and large life sciences
companies and provides a unique insight into emerging and future [...]

Boston Scientific Launches Neuroform EZ(TM) Stent System in U.S. and Europe

Company Expands Market-leading Family of Neurovascular Stents
NATICK, Massachusetts, July 28, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced the
U.S. and European launches of the Neuroform EZ(TM) Stent System, its
fourth-generation intracranial aneurysm stent system designed for use in
conjunction with endovascular coiling to treat wide-necked aneurysms. The
Company plans to launch the product immediately in both [...]

Bupa Appoints bigmouthmedia to Search Marketing Account

EDINBURGH, Scotland, July 28, 2010 – Leading international healthcare provider, Bupa, has selected
bigmouthmedia, Europe's largest and most experienced digital marketing
agency, to lead its search marketing strategy.

The new deal will see bigmouthmedia take on a major search engine
optimisation programme which will involve Bupa's key UK websites. The
project, which will be the [...]

Torchmark Corporation Reports Second Quarter 2010 Results

MCKINNEY, Texas, July 28, 2010 – Torchmark Corporation (NYSE: TMK) reported today that for the quarter
ended June 30, 2010, net income was US$1.53 per share compared with US$1.38
per share for the year-ago quarter. Net operating income for the quarter was
US$1.58 per share, a 3% per share increase compared with US$1.53 per share
for the year-ago [...]

Elsevier and PANGAEA Take Next Step in Connecting Research Articles to Data

Elsevier Articles now Graphically Enriched With Information From PANGAEA Data Sets

AMSTERDAM, July 29, 2010 – Elsevier, a world-leading publisher of scientific, technical and
medical information products and services, and PANGAEA – Publishing Network
for Geoscientific & Environmental Data – today announced their next step in
interconnecting the diverse elements of scientific research. Elsevier
articles at ScienceDirect are now [...]

Cardio3 BioSciences Hosts Visiting Scientist

This press release is issued to clarify a Cardio3 BioSciences release of July 14, 2010.

MONT-SAINT-GUIBERT, Belgium, July 29, 2010 – Cardio3 BioSciences, a leading Belgian biotechnology company specialising
in regenerative therapies for the treatment of cardiovascular diseases, today
announces that Atta Behfar, M.D. Ph.D, of Mayo Clinic in Rochester,
Minnesota, USA will spend a portion of his [...]